Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toxins and inflammatory proteins encompass a diverse group of molecules present in the gastrointestinal tract. They originate from both external sources (e.g., bacterial toxins, dietary components) and internal sources (e.g., cytokines, chemokines produced by immune cells). These molecules play crucial roles in maintaining gut homeostasis and defending against pathogens, but their dysregulation contributes significantly to the pathogenesis of various gastrointestinal disorders, including IBD. Targeting specific components offers potential therapeutic strategies but requires careful consideration due to the complex interplay of these molecules and their impact on immune function.
Varies depending on the specific molecule, ranging from direct cell damage (toxins) to immune modulation (cytokines) to signaling pathway inhibition (kinase inhibitors).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toxins and Inflammatory Proteins in the Gastrointestinal Tract.